Filed US DMF of Ferric Carboxymaltose (#035442, date of submission: Dec. 31, 2020)
2021-01-05
Filed US DMF of Eribulin Mesylate (#035358, date of submission: Nov. 30, 2020)
2021-01-05
US Patent No.US10766900B2 entitled Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof was granted on Sep 8, 2020.
